MatthewsC.The use of adrenaline in acute asthma. Br Med J1910;1:441.
2.
GayLN, LongJW. Clinical evaluation of isopropyl epinephrine in the management of bronchial asthma. JAMA1949;139:452–457.
3.
AhlquistRP. A study of the adrenergic receptors. Am J Physiol1948;153:586–600.
4.
LandsAM, ArnoldA, McAuliffJP, LuduenaFP, BrownRGJr. Differentiation of receptor systems activated by sympathomimetic amines. Nature1967;214:597–598.
5.
ShenfieldGL, PatersonJW. Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax1973;28:124–128.
6.
WoodOW, DownesJJ, ScheinkopfH, LeeksHI. Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus. J Allergy Clin Immunol1972;50:75–81.
7.
HartleyD, JackD, LuntsLHC, RitchieAG. New class of selective stimulants of beta-adrenergic receptors. Nature1968;219:861–862.
8.
ZimentI.Respiratory pharmacology and therapeutics. Philadelphia: WB Saunders Co, 1978:147–189.
9.
MathewsonHS. Promising new bronchodilator drugs. Respir Ther1982;12:47–63.
10.
SteenSN, SmithR, KuoJ, ZimentI, BeallGN. Evaluation of fenoterol in patients with chronic obstructive airway disease. Am Rev Respir Dis1976;113(Suppl):111.
11.
Symposium: Beta, adrenergic agents and other drugs in reversible airway disease. Chest1978;73(6 suppl):913–1022.
12.
BeumerHM. Comparative investigations on pirbuterol, salbutamol, and placebo aerosols in bronchial asthma. Int J Clin Pharmacol Biopharm1979;17:237–239.
13.
LittnerMR, TashkinDP, CalvareseB, BautistaM.Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma. Ann Allergy1982;48:14–20.
14.
WhitsettTL, ManionCV, WilsonMF. Cardiac, pulmonary, and neuromuscular effects of clenbuterol and terbutaline compared with placebo. Br J Clin Pharmacol1981;12:195–200.
15.
AndersonG, WilkinsE.A trial of clenbuterol in bronchial asthma. Thorax1977;32:717–719.
16.
MinatoyaH.Studies on bitolterol, di-p-toluate ester of N-tert-butylarterenol: A new long-acting bronchodilator with reduced cardiovascular effects. J Pharmacol Exp Ther1978;206:515–527.
17.
KassI, MingoTS. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects. Chest1980;78:283–287.
18.
PrimeFJ, BiancoS, KamburoffPL. Inhibition of artificially induced asthma by reproterol ("Bronchospasmin"). Curr Med Res Opin1979;6:364–370.
19.
SutherlandEW, RallTW. The relation of adenosine-3',5'-phosphate and phosphorylase to the action of catecholamines and other hormones. Pharmacol Rev1960;12:265–299.
20.
DiMezzaF, GiordanoL, ScognamiglioM, MontanaroA, MarmoE.Reproterol and the muscle of the trachea and bronchi: In vitro and in vivo comparative studies with various drugs used in the treatment of asthma. Respiration1981;42:175–183.
